Article
Cardiac & Cardiovascular Systems
Steven R. Allen, Mark S. Slaughter, Mustafa M. Ahmed, Carlo R. Bartoli, Ravi Dhingra, Gregory F. Egnaczyk, Sanjeev K. Gulati, Michael S. Kiernan, Claudius Mahr, Dan M. Meyer, Tadashi Motomura, Masahiro Ono, Ashwin Ravichandran, Alexis Shafii, Jason Smith, Behzad Soleimani, Yoshiya Toyoda, Leora T. Yarboro, Robert D. Dowling
Summary: The EVAHEART (R) 2 left ventricular assist device (EVA2) has design features that may improve clinical outcomes but require further study. The ongoing COMPETENCE trial is designed to determine if the EVA2 is non-inferior to the HM3.
JOURNAL OF HEART AND LUNG TRANSPLANTATION
(2023)
Article
Cardiac & Cardiovascular Systems
Anubodh S. Varshney, Ersilia M. DeFilippis, Jennifer A. Cowger, Ivan Netuka, Sean P. Pinney, Michael M. Givertz
Summary: With the increasing prevalence of advanced heart failure, treatment options such as heart transplantation and LVAD support have shown to improve quality of life and extend survival. Recent advancements, including the use of HeartMate 3 in clinical practice and revisions to the organ allocation system, have led to better management of LVAD-related complications. Although contemporary LVAD recipients have higher illness severity preoperatively, they have higher survival rates and lower adverse event rates compared to previous eras. However, challenges such as bleeding, infection, neurologic events, and right ventricular failure still limit the wider implementation of LVAD support. Ongoing efforts to optimize management of current LVAD devices and develop next-generation devices are expected to further enhance outcomes for patients with advanced heart failure.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
(2022)
Article
Cardiac & Cardiovascular Systems
Takayuki Gyoten, Sebastian Rojas, Henrik Fox, Masatoshi Hata, Marcus-Andre Deutsch, Rene Schramm, Jan F. Gummert, Michiel Morshuis
Summary: The study evaluated the feasibility of complete LVAD explantation with ventricular patch plasty, which showed consistent long-term results with regard to myocardial recovery.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
(2021)
Review
Medicine, General & Internal
Alessia Gambaro, Gianmarco Lombardi, Francesco Onorati, Leonardo Gottin, Flavio Luciano Ribichini
Summary: LVAD implantation has complex effects on the kidneys, particularly regarding renal function. Creatinine-based eGFR formulas help in assessing patient prognosis, while deterioration in renal function in LVAD patients negatively impacts outcomes.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
(2021)
Article
Cardiac & Cardiovascular Systems
Dominic Emerson, Joanna Chikwe, Pedro Catarino, Mohamed Hassanein, Luqin Deng, Ryan S. Cantor, Amy Roach, Robert Cole, Fardad Esmailian, Jon Kobashigawa, Jaime Moriguchi, James K. Kirklin
Summary: In contemporary practice, elderly patients receiving LVADs showed improved survival, increased functional capacity, enhanced quality of life, and fewer complications compared with younger patients.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
(2021)
Article
Cardiac & Cardiovascular Systems
Casper F. Zijderhand, Christiaan F. J. Antonides, Kevin M. Veen, Nelianne J. Verkaik, Felix Schoenrath, Jan Gummert, Petr Nemec, Bela Merkely, Francesco Musumeci, Bart Meyns, Theo M. M. H. de By, Ad J. J. C. Bogers, Kadir Caliskan
Summary: This study found an association between infection and an increased risk of cerebrovascular accidents (CVAs) in patients supported by a left ventricular assist device (LVAD), particularly in the setting of device-related or device-specific infections. This suggests the importance of strict anticoagulation management and appropriate antibiotic treatment during an infection in LVAD-supported patients.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
(2022)
Review
Cardiac & Cardiovascular Systems
Claudio A. Bravo, Andrew G. Navarro, Karanpreet K. Dhaliwal, Maziar Khorsandi, Jeffrey E. Keenan, Parvathi Mudigonda, Kevin D. O'Brien, Claudius Mahr
Summary: Left ventricular assist device (LVAD) therapy is a life-saving option for patients with advanced heart failure who do not respond to medical treatment. However, a significant percentage of LVAD patients develop right heart failure (RHF), which is associated with poor outcomes. The mechanisms of RHF are complex, involving patient factors, surgical factors, and hemodynamic factors. Despite advances in surgical techniques and LVAD technology, RHF remains a major cause of morbidity and mortality among LVAD patients. Current medical therapies for RHF are limited, and cardiac transplantation or supportive management are the only options for these patients. Efforts to predict the risk of RHF in LVAD patients have been challenging, with varying definitions of RHF in different studies. Additionally, most research in this field has focused on early-onset RHF, while late-onset RHF is increasingly recognized as a significant problem. This review aims to describe the unique physiology of the right ventricle and the changes caused by LVADs that may contribute to both early- and late-onset RHF. The available treatments for RHF, including mechanical circulatory support and medical therapies, will also be analyzed.
FRONTIERS IN CARDIOVASCULAR MEDICINE
(2022)
Article
Cardiac & Cardiovascular Systems
Ofer Havakuk, Aviram Hochstadt, Sapir Sadon, Michal Laurel Perl, Ben Sadeh, Assi Milwidsky, Orly Ran Sapir, Yoav Granot, Lior Lupu, Erez Levi, Ariel Farkash, Yanai Ben Gal, Shmuel Banai, Yan Topilsky
Summary: This study demonstrates that long-term stabilization of patients entering a left ventricular assist device (LVAD) program is possible with the use of aggressive conservative therapy.
Article
Cardiac & Cardiovascular Systems
Maryam Ajmal, Aisha Ajmal, Maryam Rizvi, Umar Salim, Lei Huang
Summary: This study aimed to investigate the changes in myocardial gene expression profile after LVAD implantation and their molecular biological significance. The results showed that inflammatory signaling pathway is crucial for the pathophysiology after LVAD implantation and chemokines mediate cardiac inflammatory response and tissue remodeling through GPCR-ligand binding.
FRONTIERS IN CARDIOVASCULAR MEDICINE
(2022)
Article
Cardiac & Cardiovascular Systems
Andrew N. Rosenbaum, Bradley W. Ternus, Siddharth Pahwa, John M. Stulak, Alfredo L. Clavell, Sarah D. Schettle, Atta Behfar, Jacob C. Jentzer
Summary: In patients undergoing left ventricular assist device implantation, right ventricular stroke work index, right heart catheterization, cardiopulmonary bypass time, and ultrafiltration are strongly associated with incident INT-LD and decreased 1-year survival. Optimization of these factors may reduce the risk of liver dysfunction but further validation is needed.
ANNALS OF THORACIC SURGERY
(2021)
Article
Medicine, General & Internal
Alexander A. Brescia, Tessa M. F. Watt, Francis D. Pagani, Thomas M. Cascino, Min Zhang, Jeffrey S. McCullough, Supriya Shore, Donald S. Likosky, Keith D. Aaronson, Michael P. Thompson
Summary: The study found that a significant proportion of LVAD recipients are ineligible for clinical trials, and that mortality rates are higher among those who are ineligible compared to those who are eligible. The results suggest that criteria for clinical trial eligibility should be more reflective of real-world experience.
Article
Hematology
Kristin Klaeske, Maja-Theresa Dieterlen, Sandra Eifert, Ute Scholz, Jens Garbade, Khalil Jawad, Franz Sieg, Michael A. Borger, Anna L. Meyer
Summary: This study compared platelet receptor expression patterns and oxidative stress levels between LVAD patients with non-surgical bleeding (NSB) and those without coagulation disorders. The findings suggested that changes in three platelet receptors (GPIb alpha, P-selectin, and PECAM-1) and elevated oxidative stress may play a role in bleeding complications following LVAD implantation.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS
(2021)
Article
Cardiac & Cardiovascular Systems
Jan D. Schmitto, Steven Shaw, Jens Garbade, Finn Gustafsson, Michiel Morshuis, Daniel Zimpfer, Jacob Lavee, Yuriy Pya, Michael Berchtold-Herz, Aijia Wang, Carlo Gazzola, Evgenij Potapov, Diyar Saeed
Summary: The long-term survival rate for primary implants of HeartMate 3 is 63.3%, and improvements in adverse events reduction, quality of life, and functional capacity were observed in patients with advanced heart failure during extended follow-up.
EUROPEAN HEART JOURNAL
(2023)
Article
Cardiac & Cardiovascular Systems
Daniel Burkhoff, Veli K. Topkara, Gabriel Sayer, Nir Uriel
Summary: This review provides a comprehensive overview of research into LVAD therapy for heart failure, including the hemodynamic effects of LVAD support and the structural, cellular, and molecular aspects of LVAD-associated reverse remodeling. The review also discusses the synergistic effects of LVAD support with heart failure therapies on clinical outcomes and myocardial biology.
CIRCULATION RESEARCH
(2021)
Article
Cardiac & Cardiovascular Systems
Amanda R. Vest, Lori Lyn Price, Anindita Chanda, Benjamin A. Sweigart, Joronia Chery, Matthew Lawrence, Lauren Parsly, Gaurav Gulati, Michael S. Kiernan, Jenica N. Upshaw, Masashi Kawabori, Gregory S. Couper, Edward Saltzman
Summary: Severe cardiac cachexia or malnutrition is commonly considered a relative contraindication to LVAD implantation. This study found that LVAD patients with cachexia had higher mortality during LVAD support, while early weight gain ≥5% during LVAD support was associated with lower mortality.
JOURNAL OF THE AMERICAN HEART ASSOCIATION
(2023)
Article
Cardiac & Cardiovascular Systems
Jacob Christensen, Filip Soeskov Davidovski, Kristoffer Grundtvig Skaarup, Mats Christian Hojbjerg Lassen, Alia Lassen, Alia Alhakak, Morten Sengelov, Anne Bjerg Nielsen, Niklas Dyrby Johansen, Henning Bundgaard, Christian Hassager, Reza Jabbari, Jorn Carlsen, Ole Kirk, Ole Peter Kristiansen, Olav Wendelboe Nielsen, Charlotte Suppli Ulrik, Pradeesh Sivapalan, Gunnar Gislason, Kasper Iversen, Jens Ulrik Staehr Jensen, Morten Schou, Anders Hviid, Tyra Grove Krause, Tor Biering-Sorensen
Summary: This study investigated whether the prognostic values of echocardiographic parameters changed with updates in treatment guidelines and the emergence of novel SARS-CoV-2 variants. The results showed that patients hospitalized during the second wave had worse left ventricular function, and reduced global longitudinal strain was associated with COVID-19-related mortality independently of wave, treatment, and SARS-CoV-2 variant.
Article
Endocrinology & Metabolism
Niels H. Brandt-Jacobsen, Mikkel Jurgens, Philip Hasbak, Peter Gaede, Peter Rossing, Jon J. Rasmussen, Camillla Fuchs Andersen, Julie L. Forman, Jens Faber, Silvio E. Inzucchi, Finn Gustafsson, Morten Schou, Caroline Kistorp
Summary: This study investigated the effects of short-term empagliflozin therapy on cardiac adipose tissue accumulation in patients with type 2 diabetes. The results showed that empagliflozin can reduce cardiac adipose tissue accumulation and improve weight and glucose metabolism. However, no correlation was observed between changes in cardiac volumetrics and cardiac adipose tissue accumulation.
DIABETES OBESITY & METABOLISM
(2023)
Article
Cardiac & Cardiovascular Systems
Frederik T. Sondergaard, Rasmus P. Beske, Martin Frydland, Jacob Eifer Moller, Ole K. L. Helgestad, Lisette Okkels Jensen, Lene Holmvang, Jens P. Goetze, Thomas Engstrom, Christian Hassager
Summary: This study found that pre-intervention plasma sST2 levels were associated with the post-procedural no-or-slow-reflow phenomenon in patients with ST-elevation myocardial infarction (STEMI), indicating that sST2 may serve as a potential biomarker to assess the extent of myocardial injury and predict prognosis in these patients.
EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE
(2023)
Article
Cardiac & Cardiovascular Systems
Pablo Jorge-Perez, Nikolaos Nikolaou, Katia Donadello, Abdo Khoury, Wilhelm Behringer, Christian Hassager, Bernd Boettiger, Alessandro Sionis, Jerry Nolan, Alain Combes, Tom Quinn, Susanna Price, Johannes Grand
Summary: This study aimed to investigate adherence to guidelines and disparities in the treatment of out-of-hospital cardiac arrest (OHCA) in European hospitals. The results showed that there is inconsistency in the management of OHCA in European hospitals and deviations from international guidelines.
EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE
(2023)
Article
Cardiac & Cardiovascular Systems
Johannes Grand, Francois Schiele, Christian Hassager, Jerry P. Nolan, Abdo Khoury, Alessandro Sionis, Nikolaos Nikolaou, Katia Donadello, Wilhelm Behringer, Bernd W. Boettiger, Alain Combes, Tom Quinn, Susanna Price, Pablo Jorge-Perez, Guido Tavazzi, Giuseppe Ristagno, Alain Cariou, Eric Bonnefoy Cudraz
Summary: This study proposes a set of quality indicators (QIs) for assessing the quality of post-out-of-hospital cardiac arrest management across Europe, with the aim of unifying and promoting quality care. These indicators include 6 primary QIs and 12 secondary QIs, ensuring reliability and accuracy through scientific methodology and selection.
EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE
(2023)
Article
Cardiac & Cardiovascular Systems
Abbas Ali Qayyum, Mette Mouridsen, Brian Nilsson, Ida Gustafsson, Morten Schou, Olav Wendelboe Nielsen, Jens Dahlgaard Hove, Anders Bruun Mathiasen, Erik Jorgensen, Steffen Helqvist, Francis Richard Joshi, Ellen Monsted Johansen, Bjarke Follin, Morten Juhl, Lisbeth Drozd Hojgaard, Mandana Haack-Sorensen, Annette Ekblond, Jens Kastrup
Summary: This study aimed to investigate the efficacy of allogeneic cell therapy for chronic ischaemic heart failure. Injections of Cardiology Stem Cell Centre Adipose tissue derived mesenchymal Stromal Cell (CSCC_ASC) were used as an add-on therapy, but no improvement in myocardial function, structure, or clinical symptoms was observed.
Article
Cardiac & Cardiovascular Systems
Karoline Amalie Rask, Tania Deis, Johan Erik Larsson, Kasper Rossing, Finn Gustafsson
Summary: Hyponatremia is associated with worse outcomes in patients with chronic heart failure and reduced ejection fraction (HFrEF). This study aimed to investigate the potential association between hemodynamic derangement and hyponatremia in HFrEF patients. The study included 502 HFrEF patients who underwent a right heart catheterization. The results showed that lower sodium levels were associated with more deranged invasive hemodynamic measurements and hyponatremia was significantly associated with a composite endpoint in these patients.
Article
Cardiac & Cardiovascular Systems
Ovidiu Chioncel, Marianna Adamo, Maria Nikolaou, John Parissis, Alexandre Mebazaa, Mehmet Birhan Yilmaz, Christian Hassager, Brenda Moura, Johann Bauersachs, Veli-Pekka Harjola, Elena-Laura Antohi, Tuvia Ben-Gal, Sean P. Collins, Vlad Anton Iliescu, Magdy Abdelhamid, Jelena Celutkiene, Stamatis Adamopoulos, Lars H. Lund, Mariantonietta Cicoira, Josep Masip, Hadi Skouri, Finn Gustafsson, Amina Rakisheva, Ingo Ahrens, Andrea Mortara, Ewa A. Janowska, Abdallah Almaghraby, Kevin Damman, Oscar Miro, Kurt Huber, Arsen Ristic, Loreena Hill, Wilfried Mullens, Alaide Chieffo, Jozef Bartunek, Pasquale Paolisso, Antoni Bayes-Genis, Stefan D. Anker, Susanna Price, Gerasimos Filippatos, Frank Ruschitzka, Petar Seferovic, Rafael Vidal-Perez, Alec Vahanian, Marco Metra, Theresa A. McDonagh, Emanuele Barbato, Andrew J. S. Coats, Giuseppe M. C. Rosano
Summary: Acute heart failure (AHF) represents a wide range of disease states caused by the interaction between acute precipitants and a patient's underlying cardiac substrate and comorbidities. Valvular heart disease (VHD) is often associated with AHF. The severity of VHD and its correlation with symptoms can be difficult to assess in AHF patients due to various factors. Evidence-based interventions targeting VHD in AHF settings are yet to be identified, making current guidelines elusive. This scientific statement aims to provide an overview of the epidemiology, pathophysiology, and treatment approach for AHF patients with VHD.
EUROPEAN JOURNAL OF HEART FAILURE
(2023)
Editorial Material
Critical Care Medicine
Markus B. Skrifvars, Janet Bray, Christian Hassager
INTENSIVE CARE MEDICINE
(2023)
Article
Multidisciplinary Sciences
Morten H. Malmborg, Ali Assad Turky Al-Kahwa, Lars D. Kober, Christian K. Torp-Pedersen, Jawad Butt, Deewa Zahir, Christian Tuxen, Mikael Poulsen, Christian Madelaire, Emil Fosbol, Gunnar Gislason, Per Hildebrandt, Charlotte Andersson, Finn Gustafsson, Morten Schou
Summary: This study found that continued follow-up in specialized heart failure clinics did not improve long-term outcomes in HFrEF patients who had already received guideline-directed therapy. There is a need for the development and implementation of new monitoring strategies.
Letter
Cardiac & Cardiovascular Systems
Seiko Nakajima Doi, Jens Jakob Thune, Jens Cosedis Nielsen, Jens Haarbo, Lars Videbaek, Rasmus Rorth, Soren Lund Kristensen, Niels Eske Bruun, Finn Gustafsson, Hans Eiskjaer, Christian Hassager, Jesper Hastrup Svendsen, Dan Eik Hofsten, Christian Torp-Pedersen, Steen Pehrson, Lars Kober, Jawad Haider Butt
CIRCULATION-HEART FAILURE
(2023)
Article
Endocrinology & Metabolism
Mikkel Jurgens, Morten Schou, Philip Hasbak, Andreas Kjaer, Emil Wolsk, Bo Zerahn, Niels H. Brandt-Jacobsen, Peter Gaede, Peter Rossing, Jens Faber, Silvio E. Inzucchi, Finn Gustafsson, Caroline Kistorp
Summary: Empagliflozin has been found to reduce measured glomerular filtration rate (mGFR), estimated plasma volume (PV), and estimated extracellular volume (ECV) in patients with type 2 diabetes (T2D) and high risk of cardiovascular events. The 13-week randomized controlled trial showed a decrease in mGFR, ECV, and PV with the use of the drug.
DIABETES OBESITY & METABOLISM
(2023)
Article
Cardiac & Cardiovascular Systems
Gerhard Poelzl, Johann Altenberger, Josep Comin-Colet, Juan F. Delgado, Francesco Fedele, Martin Jesus Garcia-Gonzalez, Finn Gustafsson, Josep Masip, Zoltan Papp, Stefan Stoerk, Hanno Ulmer, Sarah Maier, Bojan Vrtovec, Gerhard Wikstrom, Endre Zima, Axel Bauer, LeoDOR Investigators
Summary: The LeoDOR trial aimed to investigate the efficacy and safety of intermittent levosimendan therapy in patients with acute heart failure after hospitalization. The results showed that intermittent levosimendan therapy did not improve post-hospitalization clinical stability in patients recently hospitalized with reduced left ventricular ejection fraction.
EUROPEAN JOURNAL OF HEART FAILURE
(2023)
Article
Cardiac & Cardiovascular Systems
Finn Gustafsson
Summary: Catheter-based creation of atrial shunts to relieve left atrial hypertension is being investigated as a treatment for heart failure. Trials so far have shown safety and efficacy in reducing left-sided cardiac filling pressures, and ongoing trials will determine the impact on clinical outcomes.
NATURE REVIEWS CARDIOLOGY
(2023)
Article
Cardiac & Cardiovascular Systems
Mathis Groening, Morten Holdgaard Smerup, Dorte Guldbrand Nielsen, Henrik Nissen, Kim Munk, Ulrik Markus Mortensen, Helle Andersen, Morten Engholm, Jesper Bjerre, Niels Vejlstrup, Klaus Juul, Eva Vad Sondergaard, Annette Schophuus Jensen, Troels Hojsgaard Jorgensen, Hans Gustav Horsted Thyregod, Henrik orbaek Andersen, Christian Jons, Morten Helvind, Lars Sondergaard
Summary: This study aimed to assess temporal changes in the surgical management of patients with Tetralogy of Fallot, including the timing of interventions, surgical techniques, reinterventions, and survival. The results showed that in recent years, patients underwent earlier shunt palliation and intracardiac repair, with an increased use of transannular patches. Although survival rates have improved during childhood and adolescence, more patients undergo pulmonary valve replacement within the first 10 years after intracardiac repair.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
(2023)